Table 2.
Inhalable nano-formulations under clinical application
| Drug | Nanocarrier | Indication | Status | Ref |
|---|---|---|---|---|
| Amikacin | Liposome | Cystic Fibrosis patients with chronic pseudomonas aeruginosa infection | Phase 3 | NCT01316276 |
| Amikacin | Liposome | Bronchiectasis | Phase 2 | NCT00775138 |
| Salbutamol Sulphate | Niosomes | Pulmonary disease | Phase 2 | NCT03059017 |
| Remdesivir (GS-5734) and NA-831 (NEUROSIVIR) | Inhaled NP | Severe acute respiratory syndrome | Phase 1 | NCT04480333 |
| PRS-060 | Lipocalin-1 | Mild asthma | Phase 1 | NCT03574805 |